IN8BIOINAB

13F holders, Q2 2025 (June 30)
1holders −27
0new positions
17sold out
$2.09avg. 13F price*

At the end of Q2 2025, 1 institutions reported holding IN8BIO Inc. (INAB) in their 13F filings, down 27 from Q1 2025. 0 opened new positions and 17 sold out. The largest holder was BIOS Capital Management, LP ($599K).

Company
IN8BIO Inc.
CUSIP
45674E109
Latest filing quarter
Q3 2025

History

Number of 13F holders

010203040 Q1 2024: 32Q1 2024Q2 2024: 26Q2 2024Q3 2024: 26Q3 2024Q4 2024: 26Q4 2024Q1 2025: 28Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions0$0
Exits17$230K

All 13F filers, Q1 2025 → Q2 2025: 9,694,663 shares sold, net −9,694,663 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

BIOS Capital Management, LP 0.83% Reduce -96.7% 286,664 $599K

"% of holder's portfolio" is INAB's weight in each manager's 13F, not the share of IN8BIO Inc. the manager owns.